Deuterated compounds as hepatitis c virus (hcv) inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/06 (2006.01) A61P 31/14 (2006.01) C07K 5/083 (2006.01) C12N 9/50 (2006.01)

Patent

CA 2746258

The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as wet! as methods of using them to treat disorders associated with the HCV protease An illustrative inventsve compound is shown below: Formula (I).

La présente invention concerne de nouveaux composés présentant une activité inhibitrice de protéase de VHC, ainsi que des méthodes de synthèse de tels composés. Dans un autre mode de réalisation, la présente invention concerne des compositions pharmaceutiques comprenant de tels composés ainsi que des méthodes d'emplois desdits composés dans le traitement de troubles associés à la protéase de VHC. Le composé présenté ci-dessous illustre l'invention : Formule (I).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Deuterated compounds as hepatitis c virus (hcv) inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Deuterated compounds as hepatitis c virus (hcv) inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deuterated compounds as hepatitis c virus (hcv) inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2021256

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.